Original Research ARTICLE
Another Reason for Using Caffeine in Dermocosmetics: Sunscreen Adjuvant
- 1CBIOS – Research Center for Biosciences and Health Technologies, Universidade Lusófona, Lisbon, Portugal
- 2Department of Pharmacy, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
- 3IPclin, Pesquisa Integrada, Clinical Research Company, São Paulo, Brazil
The excessive exposure to ultraviolet (UV) radiation is the main cause of skin cancer, the most commonly diagnosed cancer in the world. In this context, the development of innovative and more effective sunscreens, with bioactive compounds like caffeine, displaying antioxidant and anticancer potential, is required. This research work assessed in vitro and in vivo the efficacy and safety of topical sunscreen formulations containing caffeine as an adjuvant of the UV filters. Sunscreens were prepared with 2.5% w/w caffeine or in the absence of this compound. In order to evaluate the safety of these formulations, stratum corneum hydration, skin barrier and colorimetry were assessed in vivo in healthy subjects before and after skin treatment with the samples. The efficacy of the sunscreens was assessed in vitro, using PMMA plates and a spectrophotometer equipped with an integrating sphere; and in vivo by the determination of the sun protection factor (SPF). None of the formulations caused erythema or impaired the skin barrier function. The in vitro functional characterization showed higher SPF values for the caffeine formulation. The in vivo studies also confirmed the higher SPF value of the formulation combining caffeine with the filters, compared to the caffeine-free sample. This improvement contributed to an increase of, approximately, 25% in the in vivo anti-UVB protection. In conclusion, caffeine was well tolerated by the skin and increased the photoprotective activity, being a new alternative adjuvant in sunscreens formulation.
The excessive exposure to ultraviolet (UV) radiation has led to an increase in skin cancer, the most common type of cancer diagnosed in the world (International Agency for Research on Cancer [IARC], 2012; American Cancer Society, 2016), thus increasing the relevance of the development of advanced and more effective photoprotective formulations. The original sunscreens only aimed to absorb or divert the radiation through the use of chemical or physical UV filters, but the current formulation trend is to provide a more complete protection by using bioactive compounds with beneficial properties (Cestari et al., 2012; Peres et al., 2016, 2017). Caffeine (1,3,7-trimethylpurine-2,6-dione) is a substance of the methylxanthine class (Figure 1), found especially in coffee, one of the world’s most commonly consumed beverages (Martini et al., 2016). This substance has been used in pharmaceutical and cosmetic preparations for a long time because of its beneficial effects on the skin, namely, anti-cellulite and anti-aging (Rodrigues et al., 2016). More recently, caffeine has additionally been studied for its antioxidant and anticancer effects (Shi et al., 1991; Devasagayam et al., 1996; Lu et al., 2007; Kawasumi et al., 2011), but it also has shown photoprotective properties in an animal model and, thus, exhibits a high potential to function as a sunscreen adjuvant (Lu et al., 2007).
Innovative sunscreens aim to fully protect the cutaneous tissue from the deleterious effects of UV radiation, which is considered an important risk factor associated with skin cancer (International Agency for Research on Cancer [IARC], 2012; American Cancer Society, 2016). This disease is characterized by the uncontrolled growth of abnormal skin cells that occurs when there is damage to DNA, triggering mutations or genetic defects that lead the cells to rapidly multiply and form malignant tumors (Skin Cancer Foundation, 2016). Caffeine has shown to be a potential anticancer bioactive molecule, causing apoptosis in preneoplastic cells and destruction of cells with damaged DNA (Lu et al., 2002; Lu et al., 2005; Kawasumi et al., 2011).
Additionally, exposure to UV radiation causes oxidative stress, which is also associated with skin cancer (Chen et al., 2012) by generating free radicals that damage proteins, DNA, RNA, sugar molecules, and lipids (Lu et al., 2010; Craft et al., 2012). Oral and topical applications of antioxidants, in combination with sunscreens, have shown to enhance skin photoprotection (Masnec et al., 2010). Therefore, it is likely that sunscreen products containing antioxidants could more significantly reduce skin damage, as well as skin cancer rating. Caffeine has been reported to scavenge highly reactive free radicals and to defend crucial biological molecules against these species (Devasagayam et al., 1996). Furthermore, the work of Szeto and Tong (2010) showed that caffeine at 5.0 μmol/L reduced 5-methoxypsoralen-induced phototoxicity with UVC exposure. Caffeine has been used extensively as a cosmetic ingredient not only because of its bioactivity, but also due to its low toxicity profile (Nawrot et al., 2003; Doepker et al., 2016) and numerous works can be found in the literature reporting caffeine skin permeation (Zesch et al., 1979; Dias et al., 1999; Johnson et al., 2006; Herman and Herman, 2013). In a multi-center comparison study, the caffeine mean maximal flux was found to be 2.24 μg/cm2/h (van de Sandt et al., 2002).
Considering the exposed, our research work aimed to assess in vitro and in vivo the cutaneous effects of formulations containing caffeine as an adjuvant of UV filters, in order to further establish its safety and efficacy as a functional ingredient of sunscreens.
Materials and Methods
The efficacy and safety of caffeine was evaluated in association with three UV filters: ethylhexyl methoxycinnamate (7.5%), avobenzone (3.0%) and titanium dioxide (5.0%). Oil-in-water emulsions were prepared in the absence of caffeine or containing this bioactive compound at 2.5% w/w, as shown in Table 1. The dermocosmetic vehicle contained the following ingredients (% w/w): glycerin (5.0%); ammonium acryloyldimethyltaurate/VP copolymer (1.5%); disodium EDTA (0.2%); sodium benzoate (2.5%); isopropyl myristate (5.0%); butylated hydroxytoluene (0.05%); cetearyl alcohol/dicetyl phosphate/ceteth-10 phosphate (7.0%); dibutyl adipate (3.5%); imidazolidinyl urea (1.0%); and purified water (enough to complete the 100.0% of the vehicle). All solvents and ingredients were of cosmetic, pharmaceutical or analytical grade and were used as received, without any further purification.
In vivo Skin Compatibility Assay
Twelve healthy male and female volunteers participated in the study, after oral information and written consent. This procedure was performed in accordance with the Helsinki Declaration and with the ethical standards of the local responsible committee on human experimentation. Three sites were marked in the volar forearm of the volunteers. Epicutaneous patches (Finn Chambers®, Epitest) containing either 2.5% w/w caffeine sunscreen formulation, caffeine-free sunscreen formulation, or filter paper disk soaked in distilled water (negative control), were applied at each site for 24 h.
Stratum corneum (SC) hydration was evaluated with a Corneometer® CM825 (CK Electronics GmbH), and skin barrier function was probed through the transepidermal water loss (TEWL) measured by a Tewameter® TM 300 (CK Electronics GmbH), according to the guidelines of Pinnagoda et al. (1990). Skin color was non-invasively measured by colorimetry, using a Minolta® Chroma Meter CR-300 (Minolta Camera). The parameter a∗ provided by the device reflects the red chromaticity and can be used to quantify an increase in erythema (Oliveira et al., 2016). All measurements were performed in triplicate, and the CIE Lab system was used (Piérard, 1998). The basal values were determined before patch application, and further measurements were made at 24 h, 2 h after patch removal (Oliveira et al., 2015). To minimize the effect of inter-individual variability, the results were analyzed as the ratio between the values obtained after patch application and the basal values (Oliveira et al., 2015).
In vitro Functional Characterization of the Sunscreen Formulations
Functional characterization was performed in a spectrophotometer equipped with an integrating sphere (Labsphere® UV-2000S Ultraviolet Transmittance Analyzer). The formulations were weighed (0.75 mg/cm2) and uniformly applied over polymethylmethacrylate (PMMA) plates, mimicking the rough skin surface. Samples were arranged in a suitable container covered with quartz plate, to avoid ambient interference, and thus exposed to the sunlight. The exposure of the formulations to solar radiation was conducted between late April and early June of 2014, for 2 h (11 a.m. to 1 p.m.), in São Paulo city, SP, Brazil, with an estimated irradiation intensity of 151.75 mW/m2 (Satellite Division and Environmental Systems [DSA], 2014). Replicas of three (nine measurements per PMMA plate) were performed for each sample; one previously to the solar irradiation (t0) and one after the solar stress (tf), being measured after 120 min (Lu et al., 2007).
The records of the spectrophotometric values were performed in the wavelength range between 250 and 450 nm with a progression rate of 1.0 nm (Food and Drug Administration [FDA], 2011). The estimated sun protection factor (SPF), critical wavelength (nm) and photostability were determined using the UV-2000® software (Velasco et al., 2008; Cosmetics Europe, 2011; Dario et al., 2018; Tomazelli et al., 2018).
In vivo Determination of SPF
The in vivo SPF assessment was performed in accordance with the ethical standards of the local responsible committee on human experimentation, with the Helsinki Declaration and according to the International SPF Test Method (Cosmetics Europe, 2006). The test involved 10 healthy male and female volunteers with skin Fitzpatrick types II and III, after oral information and written consent; samples were applied at 2.0 mg/cm2; the Multiport® 601 (Solar Light Company) solar UV simulator was used. Studies were conducted by IPclin (Jundiaí, SP, Brazil) (Oliveira et al., 2016; Tomazelli et al., 2018). SPF value (Eq. 1) was defined as the UV energy required to produce a minimum erythemal dose (MED), or redness, on protected skin divided by the UV energy required to produce a MED on unprotected skin (Peres et al., 2018):
Statistical analysis of the data was performed using one-way ANOVA test followed by the Tukey test for multiple comparisons. The GraphPad Prism® (Version 7) software was used, with a significance level of 5.0% (α = 0.05).
In vivo Skin Compatibility Assay
Results were analyzed as the ratio between the values obtained in each site after patch application and its respective basal values, thus decreasing the impact of inter-individual variability. Although a slight increase in SC hydration was observed, probably attributable to occlusion or to the emollients in the O/W emulsion, no differences were established among the sites treated with the formulations and the negative control (Figure 2). No significant impact on the TEWL and, therefore, in the skin barrier function was observed in any of the sites (Figure 3). The colorimetry assay was employed to further ascertain the cutaneous compatibility of the formulations. A significant decrease in the skin redness was detected after treatment with the two formulations in comparison with the negative control, indicating that the formulations were well-tolerated and did not cause erythema (Figure 4).
Figure 2. Variation in stratum corneum (SC) hydration before and after application of the different formulations. The results were analyzed as the ratio between the values obtained after patch application over the basal values. Different letters for the same parameter indicate statistically significant differences between samples (p < 0.05; mean + SD, n = 12).
Figure 3. Variation in transepidermal water loss before and after application of the different formulations. The results were analyzed as the ratio between the values obtained after patch application over the basal values. Different letters for the same parameter indicate statistically significant differences between samples (p < 0.05; mean + SD, n = 12).
Figure 4. Variation in skin redness before and after application of the different formulations. The results were analyzed as the ratio between the values obtained after patch application over the basal values. Different letters for the same parameter indicate statistically significant differences between samples (p < 0.05; mean + SD, n = 12).
In vitro Functional Characterization of the Formulations
The functional characterization was analyzed in the absence (caffeine-free) and at 2.5% w/w caffeine, in different solar irradiation times (t0 and tf) (Table 2). According to this data, it was observed that irradiation, in function of the time of exposure, affected positively the SPF values of both caffeine-free and 2.5% caffeine samples, but the latter provided significantly higher SPF values.
Table 2. In vitro SPF and critical wavelength (nm) values (mean and standard deviation) as a function of irradiation time.
In vivo Determination of SPF
The value measured in the 2.5% caffeine formulation, with SPF of 19.34, was statistically significantly higher when compared to the caffeine-free sample, with SPF 15.43 (Table 3).
The sunscreen formulation containing caffeine at 2.5% w/w presented a higher SPF value on both in vitro and in vivo tests when compared to the caffeine-free sample. This improvement contributed to an increase of, approximately, 25% in the in vivo anti-UVB protection. In addition, the in vivo skin compatibility assays showed that the formulation with caffeine did not cause a negative impact in SC hydration or in skin barrier function, nor did they cause any erythema, even when applied under occlusion for 24 h.
Caffeine has been widely studied for its potential beneficial actions in the human organism. Shi et al. (1991) reported that caffeine effectively scavenged the hydroxyl radical by using an electron spin resonance spin trapping mechanism. Devasagayam et al. (1996) showed its antioxidant effect by inhibition of lipid peroxidation of rat liver microsomes induced by hydroxyl radical, peroxyl radical and singlet oxygen. These authors registered that the caffeine antioxidant activity was similar to glutathione and that it was higher than ascorbic acid7. Other studies have shown the anticancer effects of caffeine. It was demonstrated that the topical application of caffeine possibly caused apoptosis in preneoplastic cells (Lu et al., 2002, 2005). Kawasumi et al. (2011) researched the protection of UV-induced skin carcinogenesis on SKH-1 hairless mice using topical application of caffeine, showing that this compound promoted the activity of the ATR gene, involved in the destruction of cells with damaged DNA, consequently more likely to become cancerous cells. Moreover, caffeine has shown to inhibit UVB-induced carcinogenesis (Lu et al., 2007). However, to date, there is no data in the specialized literature that proves its photoprotective effect by the SPF establishment.
In our study, caffeine alone did not provide a significant SPF value (data not shown), Nevertheless, when in association with the sunscreen system, containing two chemical UV filters - ethylhexyl methoxycinnamate and avobenzone - and the physical filter titanium dioxide, it acted as a SPF enhancer. This improvement can probably be attributed to an antioxidant or an anti-inflammatory activity, attenuating the erythema caused by the UV radiation or even, delaying the erythema formation. Additionally, caffeine contributed as a photostabilizer for the chemical filters, which are known, when associated, to undergo an irreversible photochemical reaction leading to loss of UV protection (Dondi et al., 2006). Other studies conducted by our group with antioxidants, such as rutin (Tomazelli et al., 2018) and ferulic acid (Peres et al., 2018), have shown to be similarly advantageous in sunscreen formulations.
According to the specialized literature, caffeine absorbs in the spectral range between 244 and 295 nm in water, with λ at 272.8 nm (Atomssa and Gholap, 2011). Also, its molar absorption coefficient (max ε) in water, which is how strongly a substance absorbs radiation of a given frequency, is 920 ± 0.85 m2mol-1, possibly not being enough to develop on its own a substantial SPF (Atomssa and Gholap, 2011). However, it should be noted that the SPF value of 2.5% w/w caffeine associated with the UV filters, after the sunlight exposure, was significantly higher than the one measured before this stress condition, and provided a much higher increase that the one observed in the caffeine-free formulation. The main role of organic molecules in sunscreens (UV filters), most of which contain aromatic rings conjugated with carbonyl groups, is to absorb UVA and/or UVB radiation and convert the electronic excitation into, for example, vibrational energy, without modifying themselves (Karsili et al., 2014; Tan et al., 2014). However, in a photochemical organic reaction, molecule alterations may occur, like electrocyclic reactions, radical reactions, photoisomerization, and Norrish reactions, which could change the photoprotective propriety of the system (Klan and Wirz, 2009; Turro et al., 2010). Horbury et al. (2016) showed that the photoexcitation of ferulic acid and caffeic acid resulted in an isomerization pathway, which the cis-isomer provides a comparable level of photoprotection as the trans-. Karsili et al. (2014) described that adding the hydroxy/methoxy groups to the ring of molecules, like cinnamic acid, results in red-shifting (increasing in wavelength) the UV absorption spectrum, matching better for sunscreen applications. Considering the exposed, it is plausible to infer that the caffeine molecule could pass through modifications when electronically excited, developing a better sunscreen activity by SPF enhancement.
Caffeine has been reported (Devasagayam and Kesavan, 1996; Horbury et al., 2016) to scavenge highly reactive free radicals, including hydroxyl radicals and excited states of oxygen, and to protect crucial biological molecules against these species. Also, studies indicated that caffeine degraded slowly by direct photolysis (>170 h in artificial sunlight) (Jacobs et al., 2012). Moreover, experimental and in silico studies carried out by Dalmázio et al. (2005) and León-Carmona and Galano (2011a), respectively, have reported that caffeine has the ability to capture free radicals and undergo subsequent degradation processes, especially by radical formation of adducts which can generate species that cause wavelength-shifting. The authors have determined caffeine degradation by UV/TiO2 system, which is known to produce in situ hydroxyl-radical species (Dalmázio et al., 2005). The proposed mechanism involves successive steps of hydroxylation and oxidation to generate compounds such as CO2, H2O and NH3, and NH2Me (Figure 5). According to Dalmázio et al. (2005), the results indicated that, although caffeine was almost completely consumed, mineralization (CO2, H2O, and NH3 formation) occurred slower under oxidative conditions in the presence of UV/TiO2. Noteworthy, in other systems studied, the authors have achieved very similar results in the identification of species formed by caffeine degradation. Therefore, degradation of caffeine is likely to generate persistent organic intermediates that are not so efficiently oxidized as compared to caffeine and this could be the explanation to increased photoprotection.
Figure 5. Degradation reaction of caffeine (1). The photolytic degradation mechanism of caffeine (1) to dimethylparabanic acid (2) involves the hydroxy radical attack on caffeine’s double bond D4,8. Hydroxylation and subsequent oxidation processes generate compounds 2 and 3, which the substances CO2, NH3, and NH2Me are formed more slowly. Noteworthy, the oxidation products 4, 5, and 6 may also be converted into dimethylparabanic acid (2) via a similar mechanism.
One other hypothesis is that caffeine (1) could be metabolized when topically applied on the human cutaneous tissue, and these metabolites might be related to the enhanced photoprotection obtained in vivo and to beneficial actions (Figure 6). Caffeine is mainly metabolized by CYP1A2 in the liver, and this enzyme is also present in our skin at low concentrations, which could lead to the formation of paraxanthine (7) (Hakooz, 2009; Luu-The et al., 2009; Hu et al., 2010). Paraxanthine (7) may be once more metabolized into 1,7-dimethyluric acid (8) by CYP1A2 (Hakooz, 2009). Another important metabolite pathway that could happen in the skin is the metabolization of caffeine (1) by CYP1A2 or by CYP2C9 (likewise present in the skin at low concentrations), generating theophylline (9) (Hakooz, 2009; Luu-The et al., 2009; Hu et al., 2010). Theophylline (9) is also metabolized by CYP1A2, generating 1-methylxanthine (10), which is then metabolized by xanthine dehydrogenase/oxidase (present in epidermal keratinocytes), forming 1-methyluric acid (11) (Shalbaf et al., 2008; Hakooz, 2009).
Figure 6. Metabolic pathways for caffeine (1). In blue, positions that suffered metabolic reactions.
Scurachio et al. (2016) demonstrated that 1,7-dimethyluric acid (10) and 1-methyluric acid (11) were efficient as quenchers of triplet riboflavin (which causes oxidative damage to proteins, vitamins, lipids and sterols upon UV absorption) using transient absorption laser flash photolysis. Compound 11 is one of the main metabolic products of caffeine (1) in humans, and it has been reported to act as an antioxidant (Lee, 2000). This molecule is predicted to moderately protect lipids against peroxyl oxidation, being a better radical scavenger than its precursor, caffeine (León-Carmona and Galano, 2011b). Moreover, León-Carmona and Galano (2011a,b) suggested that the antiradical activity of caffeine might be explained more by the action of its own metabolites, rather than by its direct activity. Thus, the significant antioxidant activity of (11) was illustrated by oxygen-radical absorbing capacity (ORAC) and inhibition of LDL peroxidation (Lee, 2000).
In conclusion, caffeine and some of its metabolites could be acting beneficially in the photoprotection and antioxidant activities, besides a relevant photostabilization profile. In this research work, the interest of combining caffeine with UV filters in a sunscreen formulation was established, and its cutaneous biocompatibility was also confirmed. However, a phototoxicity assay would be indispensable to fully assess the safety of this type of ingredient. Higher SPF was obtained when caffeine was combined with the UV filters ethylhexyl methoxycinnamate, avobenzone and titanium dioxide. Caffeine seemed to be, thus, an interesting bioactive compound for use in sunscreens, acting in synergy as a photoprotector and a photostabilizer.
This study was carried out in accordance with the recommendations of international standards and International Sun Protection Factor Test Method, (Cosmetics Europe, 2006). The protocol was approved by the (CEP-FCF-USP and CBIOS). All subjects gave written informed consent in accordance with the Declaration of Helsinki.
AB and CR conceived and designed the experiments. VT, CR, FS, and CdO performed the experiments. CdO, CR, RS, RP-F, and AB analyzed the data. CR, TdA, EM, CdO, RS, RP-F, MV, and AB wrote the manuscript.
The authors gratefully acknowledge the financial support of the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP; processes 13/08535-0, 13/18689-5, and 12/04435-9) and the National Council for Scientific and Technological Development (CNPq-Brasil). This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) – Finance Code 001. This work was also financed by Portuguese funds through the FCT – Foundation for Science and Technology, I.P., under the project UID/DTP/04567/2016.
Conflict of Interest Statement
FS was employed by IPclin.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
American Cancer Society (2016). Available at: http://www.cancer.org/cancer/skincancer/index (accessed April 01, 2017).
Craft, B. D., Kerrihard, A. L., Amarowicz, R., and Pegg, R. B. (2012). Phenol-based antioxidants and the in vitro methods used for their assessment. Compr. Rev. Food Sci. Food Saf. 11, 148–173. doi: 10.1111/j.1541-4337.2011.00173.x
Dalmázio, I., Santos, L. S., Lopes, R. P., Eberlin, M. N., and Augusti, R. (2005). Advanced oxidation of caffeine in water: on-line and real-time monitoring by electrospray ionization mass spectrometry. Environ. Sci. Technol. 39, 5982–5988. doi: 10.1021/es047985v
Dario, M. F., Oliveira, F. F., Marins, D. S. S., Baby, A. R., Velasco, M. V. R., Löbenberg, R., et al. (2018). Synergistic photoprotective activity of nanocarrier containing oil of Acrocomia aculeata (Jacq.) Lodd. Ex. Martius - Arecaceae. Ind. Crops Prod. 112, 305–312. doi: 10.1016/j.indcrop.2017.12.021
Devasagayam, T. P., Kamat, J. P., Mohan, H., and Kesavan, P. C. (1996). Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species. Biochim. Biophys. Acta 1282, 63–70. doi: 10.1016/0005-2736(96)00040-5
Dias, M., Farinha, A., Faustino, E., Hadgraft, J., Pais, J., and Toscano, C. (1999). Topical delivery of caffeine from some commercial formulations. Int. J. Pharm. 182, 41–47. doi: 10.1016/s0378-5173(99)00067-8
Doepker, C., Lieberman, H. R., Smith, A. P., Peck, J. D., El-Sohemy, A., and Welsh, B. T. (2016). Caffeine: friend or foe? Annu. Rev. Food Sci. Technol. 7, 117–137. doi: 10.1146/annurev-food-041715-033243
Dondi, D., Albini, A., and Serpone, N. (2006). Interactions between different solar UVB/UVA filters contained in commercial suncreams and consequent loss of UV protection. Photochem. Photobiol. Sci. 5, 835–843. doi: 10.1039/b606768a
Food and Drug Administration [FDA] (2011). Department of Health and Human Services. 21 CRF parts 201 and 310. Labeling and Effectiveness Testing: Sunscreen Drug Products for Over-The-Counter Human Use — Small Entity Compliance Guide; Final Rule, Vol. 76. Silver Spring, MD: Food and Drug Administration, 46.
Hakooz, N. M. (2009). Caffeine metabolic ratios for the in vivo evaluation of CYP1A2, N-acetyltransferase 2, xanthine oxidase and CYP2A6 enzymatic activities. Curr. Drug Metab. 10, 329–338. doi: 10.2174/138920009788499003
Horbury, M. D., Baker, L. A., Quan, W. D., Greenough, S. E., and Stavros, V. G. (2016). Photodynamics of potent antioxidants: ferulic and caffeic acids. Phys. Chem. Chem. Phys. 18, 17691–17697. doi: 10.1039/c6cp01595f
Hu, T., Khambatta, Z. S., Hayden, P. J., Bolmarcich, J., Binder, R. L., Robinson, M. K., et al. (2010). Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin. Toxicol. In Vitro 24, 1450–1463. doi: 10.1016/j.tiv.2010.03.013
International Agency for Research on Cancer [IARC] (2012). A Review of Human Carcinogens. Radiation. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. D. Lyon: International Agency for Research on Cancer.
Jacobs, L. E., Weavers, L. K., Houtz, E. F., and Chin, Y. P. (2012). Photosensitized degradation of caffeine: role of fulvic acids and nitrate. Chemosphere 86, 124–129. doi: 10.1016/j.chemosphere.2011.09.052
Johnson, S., Moss, G., and Thomas, C. P. (2006). In vitro transdermal delivery of caffeine, theobromine, theophylline and catechin from extract of Guarana, Paullinia Cupana. Int. J. Pharm. 317, 26–31. doi: 10.1016/j.ijpharm.2006.02.042
Karsili, T. N., Marchetti, B., Ashfold, M. N., and Domcke, W. (2014). Ab initio study of potential ultrafast internal conversion routes in oxybenzone, caffeic acid, and ferulic acid: implications for sunscreens. J. Phys. Chem. A 118, 11999–12010. doi: 10.1021/jp507282d
Kawasumi, M., Lemos, B., Bradner, J. E., Thibodeau, R., Kim, Y. S., Schmidt, M., et al. (2011). Protection from UV-induced skin carcinogenesis by genetic inhibition of the ataxia telangiectasia and Rad3-related (ATR) kinase. Proc. Natl. Acad. Sci. U.S.A. 108, 13716–13721. doi: 10.1073/pnas.1111378108
Lee, C. (2000). Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation. Clin. Chim. Acta 295, 141–154. doi: 10.1016/s0009-8981(00)00201-1
Lu, J., Lin, P. H., Yao, Q., and Chen, C. (2010). Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J. Cell. Mol. Med. 14, 840–860. doi: 10.1111/j.1582-4934.2009.00897.x
Lu, Y. P., Lou, Y. R., Liao, J., Xie, J. G., Peng, Q. Y., Yang, C. S., et al. (2005). Administration of green tea or caffeine enhances the disappearance of UVB-induced patches of mutant p53 positive epidermal cells in SKH-1 mice. Carcinogenesis 26, 1465–1472. doi: 10.1093/carcin/bgi086
Lu, Y. P., Lou, Y. R., Xie, J. G., Peng, Q. Y., Liao, J., Yang, C. S., et al. (2002). Topical applications of caffeine or (–)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc. Natl. Acad. Sci. U.S.A. 99, 12455–12460. doi: 10.1073/pnas.182429899
Lu, Y. P., Lou, Y. R., Xie, J. G., Peng, Q. Y., Zhou, S., Lin, Y., et al. (2007). Caffeine and caffeine sodium benzoate have a sunscreen effect, enhance UVB-induced apoptosis, and inhibit UVB-induced skin carcinogenesis in SKH-1 mice. Carcinogenesis 28, 199–206. doi: 10.1093/carcin/bgl112
Luu-The, V., Duche, D., Ferraris, C., Meunier, J. R., Leclaire, J., and Labrie, F. (2009). Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models Episkin and full thickness model from Episkin. J. Steroid Biochem. Mol. Biol. 116, 178–186. doi: 10.1016/j.jsbmb.2009.05.011
Martini, D., Del Bo’, C., Tassotti, M., Riso, P., Del Rio, D., Brighenti, F., et al. (2016). Coffee consumption and oxidative stress: a review of human intervention studies. Molecules 21:979. doi: 10.3390/molecules21080979
Oliveira, C. A., Dario, M. F., Sarruf, F. D., Mariz, I. F., Velasco, M. V., Rosado, C., et al. (2016). Safety and efficacy evaluation of gelatin-based nanoparticles associated with UV filters. Colloids Surf. B Biointerfaces 140, 531–537. doi: 10.1016/j.colsurfb.2015.11.031
Oliveira, C. A., Peres, D. D., Rugno, C. M., Kojima, M., Pinto, C. A., Consiglieri, V. O., et al. (2015). Functional photostability and cutaneous compatibility of bioactive UVA sun care products. J. Photochem. Photobiol. B Biol. 148, 154–159. doi: 10.1016/j.jphotobiol.2015.04.007
Peres, D. A., de Oliveira, C. A., da Costa, M. S., Tokunaga, V. K., Mota, J. P., Rosado, C., et al. (2016). Rutin increases critical wavelength of systems containing a single UV filter and with good skin compatibility. Skin Res. Technol. 22, 325–333. doi: 10.1111/srt.12265
Peres, D. D., Ariede, M. B., Candido, T. M., de Almeida, T. S., Lourenço, F. R., Consiglieri, V. O., et al. (2017). Quality by design (QbD), process analytical technology (PAT), and design of experiment applied to the development of multifunctional sunscreens. Drug Dev. Ind. Pharm. 43, 246–256. doi: 10.1080/03639045.2016.1236809
Peres, D. D., Sarruf, F. D., de Oliveira, C. A., Velasco, M. V. R., and Baby, A. R. (2018). Ferulic acid photoprotective properties in association with UV filters: multifunctional sunscreen with improved SPF and UVA-PF. J. Photochem. Photobiol. B Biol. 185, 46–49. doi: 10.1016/j.jphotobiol.2018.05.026
Rodrigues, F., Alves, A. C., Nunes, C., Sarmento, B., Amaral, M. H., Reis, S., et al. (2016). Permeation of topically applied caffeine from a food by product in cosmetic formulations: is nanoscale in vitro approach an option? Int. J. Pharm. 513, 496–503. doi: 10.1016/j.ijpharm.2016.09.059
Satellite Division and Environmental Systems [DSA] (2014). Ultraviolet Index. Available at: http://satelite.cptec.inpe.br/acervo/acervo.formulario.logic (accessed May 22, 2017)
Scurachio, R. S., Mattiucci, F., Santos, W. G., Skibsted, L. H., and Cardoso, D. R. (2016). Caffeine metabolites not caffeine protect against riboflavin photosensitized oxidative damage related to skin and eye health. J. Photochem. Photobiol. B Biol. 163, 277–283. doi: 10.1016/j.jphotobiol.2016.08.042
Shalbaf, M., Gibbons, N. C., Wood, J. M., Maitland, D. J., Rokos, H., Elwary, S. M., et al. (2008). Presence of epidermal allantoin further supports oxidative stress in vitiligo. Exp. Dermatol. 17, 761–770. doi: 10.1111/j.1600-0625.2008.00697.x
Skin Cancer Foundation (2016). Available at: http://www.skincancer.org/skin-cancer-information (accessed April 01, 2017).
Tomazelli, L. C., Ramos, M. M. A., Sauce, R., Cândido, T. M., Sarruf, F. D., Pinto, C. A. S. O., et al. (2018). SPF enhancement provided by rutin in a multifunctional sunscreen. Int. J. Pharm. 552, 401–406. doi: 10.1016/j.ijpharm.2018.10.015
van de Sandt, J. J., van Burgsteden, J. A., Cage, S., Carmichael, P. L., Dick, I., Kenyon, S., et al. (2002). In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. Regul. Toxicol. Pharm. 39, 271–281. doi: 10.1016/j.yrtph.2004.02.004
Velasco, M. V., Sarruf, F. D., Salgado-Santos, I. M., Haroutiounian-Filho, C. A., Kaneko, T. M., and Baby, A. R. (2008). Broad spectrum bioactive sunscreens. Int. J. Pharm. 363, 50–57. doi: 10.1016/j.ijpharm.2008.06.031
Keywords: caffeine, sunscreen, sun protection factor, UV radiation, cutaneous compatibility
Citation: Rosado C, Tokunaga VK, Sauce R, de Oliveira CA, Sarruf FD, Parise-Filho R, Maurício E, de Almeida TS, Velasco MVR and Baby AR (2019) Another Reason for Using Caffeine in Dermocosmetics: Sunscreen Adjuvant. Front. Physiol. 10:519. doi: 10.3389/fphys.2019.00519
Received: 29 May 2018; Accepted: 11 April 2019;
Published: 03 May 2019.
Edited by:Enzo Berardesca, San Gallicano Hospital, Italy
Reviewed by:Paola Perugini, University of Pavia, Italy
Ivan Domicio da Silva Souza, Independent Researcher, Philadelphia, PA, United States
Copyright © 2019 Rosado, Tokunaga, Sauce, de Oliveira, Sarruf, Parise-Filho, Maurício, de Almeida, Velasco and Baby. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: André Rolim Baby, firstname.lastname@example.org
†Shared first authorship